Barclays (LON:BARC) analyst Steven Valiquette maintained a Buy rating on Cigna Corp on Friday, setting a price target of $275, which is approximately 31.39% above the present share price of $209.3.
Valiquette expects Cigna Corp to post earnings per share (EPS) of $3.33 for the third quarter of 2021.
The current consensus among 16 TipRanks analysts is for a Strong Buy rating of shares in Cigna, with an average price target of $278.5.
The analysts price targets range from a high of $321 to a low of $240.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $40.98 billion and a net profit of $0. The company's market cap is $71.71 billion.
According to TipRanks.com, Barclays analyst Steven Valiquette is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 1.7% and a 54.55% success rate.
Founded in 1792, Cigna Corporation (NYSE:CI) is a Connecticut-based global health services company, which provides insurance and related products and services. It operates through the following segments: Health Services, Integrated Medical, International Markets, and Group Disability and Other.